Results 131 to 140 of about 35,745 (266)

Oral vaccines for preventing cholera

, 2011
David Sinclair, Katharine Abba, Khalequ Zaman, Firdausi Qadri, Patricia M. Graves   +4 more
openalex   +2 more sources

Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients [PDF]

, 2018
Jianguang Ji, Jan Sundquist, Kristina Sundquist   +2 more
openalex   +1 more source

Randomized, Controlled Human Challenge Study of the Safety, Immunogenicity, and Protective Efficacy of a Single Dose of Peru-15, a Live Attenuated Oral Cholera Vaccine [PDF]

, 2002
Mitchell B. Cohen, Ralph A. Giannella, Judy A. Bean, David N. Taylor, Susan Parker, Amy Hoeper, Stephen Wowk, Jennifer Hawkins, Sims K. Kochi, Gilbert Schiff, Kevin Killeen   +10 more
openalex   +1 more source

Cholera rages in Africa and the Middle East: A narrative review on challenges and solutions

Health Science Reports
Background and Aim Cholera is a life‐threatening infectious disease that is still one of the most common acute watery diarrheal diseases in the world today.
Abdulrahman K. Ahmed, Victor Coll Sijercic, Mahad S. Akhtar, Ahmed Elbayomy, Mohamed A. Marouf, Mahlet S. Zeleke, Reem Sayad, Abdelrahman Abdelshafi, Nicholas J. Laird, Mohamed A. El‐Mokhtar, Gregory R. Ruthig, Helal F. Hetta   +11 more
doaj   +1 more source

Vaccination of Cows with a Combined Rotavirus/Enterotoxigenic "E. Coli" K99 Vaccine to Protect Newborn Calves Against Diarrhoea [PDF]

, 1983
Bachmann, P. A., Baljer, G., Eichhorn, Werner, Plank, P., Schneider, P.   +4 more
core   +1 more source

Strategic evaluations and techno-economic networks. Vaccine innovation in the Cuban biotech sector: for public health – or for profits? [PDF]

In this paper the Cuban biotech sector with its highly integrated vaccine industry is analyzed in the perspective of the techno-economic network model of Michel Callon. The paper discusses the strategic evaluations that have been performed in the sector.
Jens Plahte
core  

An Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, India

, 2015
Vittal Mogasale, Shantanu Kumar Kar, Jong‐Hoon Kim, Vijayalaxmi V. Mogasale, Anna Salomi Kerketta, Bikash Patnaik, Shyam Bandhu Rath, Mahesh Puri, Young Ae You, Hemant Kumar Khuntia, Brian Maskery, Thomas F. Wierzba, Binod Sah, Thomas F. Wierzba, Binod Sah   +14 more
openalex   +2 more sources

A Proposal for Safety Standards for Human Use of Cholera Toxin (or <i>Escherichia coli</i> Heat-Labile Enterotoxin) Derivatives as an Adjuvant of Nasal Inactivated Influenza Vaccine

, 2000
S Tamura, Takeshi Kurata
openalex   +2 more sources

Cost of oral cholera vaccine delivery in a mass immunization program for children in urban Bangladesh

, 2022
Abdur Razzaque Sarker, Ashraful Islam Khan, Md Taufiqul Islam, Fahima Chowdhury, Farhana Khanam, Sophie Kang, Faisal Ahmmed, Justin Im, Deok Ryun Kim, Birkneh Tilahun Tadesse, Tasnuva Ahmed, Asma Binte Aziz, Masuma Hoque, Juyeon Park, Xinxue Liu, Gideok Pak, Khalequ Zaman, Florian Marks, Jérôme H. Kim, John D Clemens, Firdausi Qadri   +20 more
openalex   +1 more source

Proinflammatory Responses in the Murine Brain after Intranasal Delivery of Cholera Toxin: Implications for the Use of AB Toxins as Adjuvants in Intranasal Vaccines [PDF]

, 2005
Michelle E. Armstrong, Ed C. Lavelle, Christine E. Loscher, Marina A. Lynch, Kingston H. G. Mills   +4 more
openalex   +1 more source